Discontinued in 2004. UroOncology aims to publish all aspects of clinical research and management of cancer of the urinary tract and male reproductive organs. The target audience uniquely encompasses a multidisciplinary group of clinicians with a special interest in treating patients with urological cancer: urologists, medical oncologists and radiation oncologists. The journal will feature prestigious reviews, original papers, selected abstracts of scientific meetings, basic science updates, a directory of urological trials (including contact points and status reports) and scientific meeting notification. Material published will be evidence-based in accordance with current thinking and following the requirements for CME, and the cross-disciplinary approach will be further promoted by the inclusion of papers on statistics, meta-analysis and ethics.
- Further information
- Category Links